Buy Cellectis SA Stock | CLLS Stock Price & Latest News | Public
CLLS

Cellectis SA

$0.00 (0.00%)Today

    About CLLS

    Cellectis SA engages as a biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. It offers Gene editing and Immuno-oncology. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquarter...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.47
    0.05
    -0.36
    -0.78
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.78

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,02B
    Volume5,69k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$24.23
    1 Year Low$7.32
    Open$23.00
    High$24.21
    Low$23.00

    Buy any stock with any amount of money.

    Download the App
    Download the app